JP2020531411A5 - - Google Patents

Info

Publication number
JP2020531411A5
JP2020531411A5 JP2020505786A JP2020505786A JP2020531411A5 JP 2020531411 A5 JP2020531411 A5 JP 2020531411A5 JP 2020505786 A JP2020505786 A JP 2020505786A JP 2020505786 A JP2020505786 A JP 2020505786A JP 2020531411 A5 JP2020531411 A5 JP 2020531411A5
Authority
JP
Japan
Prior art keywords
poi
matrix
protein
eluate pool
buffer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2020505786A
Other languages
English (en)
Japanese (ja)
Other versions
JP2020531411A (ja
JP7097433B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2018/046919 external-priority patent/WO2019036626A1/en
Publication of JP2020531411A publication Critical patent/JP2020531411A/ja
Publication of JP2020531411A5 publication Critical patent/JP2020531411A5/ja
Application granted granted Critical
Publication of JP7097433B2 publication Critical patent/JP7097433B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2020505786A 2017-08-17 2018-08-17 宿主細胞ガレクチンおよび他の夾雑物からグリコシル化タンパク質を精製する方法 Active JP7097433B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201762546558P 2017-08-17 2017-08-17
US62/546,558 2017-08-17
PCT/US2018/046919 WO2019036626A1 (en) 2017-08-17 2018-08-17 PROCESS FOR PURIFYING GLYCOSYLATED PROTEIN FROM GALECTINES AND OTHER HOST CELL CONTAMINANTS

Publications (3)

Publication Number Publication Date
JP2020531411A JP2020531411A (ja) 2020-11-05
JP2020531411A5 true JP2020531411A5 (cg-RX-API-DMAC7.html) 2022-05-09
JP7097433B2 JP7097433B2 (ja) 2022-07-07

Family

ID=63684424

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2020505786A Active JP7097433B2 (ja) 2017-08-17 2018-08-17 宿主細胞ガレクチンおよび他の夾雑物からグリコシル化タンパク質を精製する方法

Country Status (10)

Country Link
US (1) US11358983B2 (cg-RX-API-DMAC7.html)
EP (1) EP3668985B1 (cg-RX-API-DMAC7.html)
JP (1) JP7097433B2 (cg-RX-API-DMAC7.html)
KR (1) KR102578087B1 (cg-RX-API-DMAC7.html)
CN (1) CN111344410B (cg-RX-API-DMAC7.html)
CA (1) CA3067735A1 (cg-RX-API-DMAC7.html)
DK (1) DK3668985T3 (cg-RX-API-DMAC7.html)
ES (1) ES2887046T3 (cg-RX-API-DMAC7.html)
MY (1) MY199833A (cg-RX-API-DMAC7.html)
WO (1) WO2019036626A1 (cg-RX-API-DMAC7.html)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY199833A (en) 2017-08-17 2023-11-24 Just Evotec Biologics Inc Method of purifying glycosylated protein from host cell galectins and other contaminants
IL309560B2 (en) * 2019-12-06 2025-05-01 Regeneron Pharma Anti-VEGF protein preparations and methods for their production
MX2022013812A (es) 2020-05-08 2022-12-15 Regeneron Pharma Trampas y mini-trampas de vegf y metodos para el tratamiento de trastornos oculares y cancer.
US20250215417A1 (en) * 2022-03-30 2025-07-03 Ionis Pharmaceuticals, Inc. Methods for Separating Certain Oligonucleotide Compounds
TW202502843A (zh) * 2023-03-17 2025-01-16 日商丸善石油化學股份有限公司 聚合物之製造方法

Family Cites Families (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USRE30985E (en) 1978-01-01 1982-06-29 Serum-free cell culture media
US4560655A (en) 1982-12-16 1985-12-24 Immunex Corporation Serum-free cell culture medium and process for making same
US4657866A (en) 1982-12-21 1987-04-14 Sudhir Kumar Serum-free, synthetic, completely chemically defined tissue culture media
US4816567A (en) 1983-04-08 1989-03-28 Genentech, Inc. Recombinant immunoglobin preparations
US4767704A (en) 1983-10-07 1988-08-30 Columbia University In The City Of New York Protein-free culture medium
GB8516415D0 (en) 1985-06-28 1985-07-31 Celltech Ltd Culture of animal cells
US4927762A (en) 1986-04-01 1990-05-22 Cell Enterprises, Inc. Cell culture medium with antioxidant
ATE135045T1 (de) 1988-07-23 1996-03-15 Delta Biotechnology Ltd Sekretorische leader-sequenzen
WO1990003430A1 (en) 1988-09-23 1990-04-05 Cetus Corporation Cell culture medium for enhanced cell growth, culture longevity and product expression
US5122469A (en) 1990-10-03 1992-06-16 Genentech, Inc. Method for culturing Chinese hamster ovary cells to improve production of recombinant proteins
US5429746A (en) 1994-02-22 1995-07-04 Smith Kline Beecham Corporation Antibody purification
AT403989B (de) 1996-09-16 1998-07-27 Immuno Ag Verfahren zur herstellung eines plasmaprotein-hältigen arzneimittels
ES2293661T3 (es) 1996-11-27 2008-03-16 Genentech, Inc. Purificacion por afinidad de polipeptido en una matriz de proteinas a.
US6022952A (en) 1998-04-01 2000-02-08 University Of Alberta Compositions and methods for protein secretion
US6660843B1 (en) 1998-10-23 2003-12-09 Amgen Inc. Modified peptides as therapeutic agents
JP4475814B2 (ja) 1998-11-20 2010-06-09 扶桑薬品工業株式会社 タンパク質発現ベクターとその使用
CA2368068A1 (en) 1999-03-18 2000-09-21 Steven M. Ruben 27 human secreted proteins
US7303746B2 (en) 1999-06-08 2007-12-04 Regeneron Pharmaceuticals, Inc. Methods of treating eye disorders with modified chimeric polypeptides
CN101433715B (zh) 1999-06-08 2013-04-17 里珍纳龙药品有限公司 具有改善的药物动力学特性的修饰嵌合多肽
US7306799B2 (en) 1999-06-08 2007-12-11 Regeneron Pharmaceuticals, Inc. Use of VEGF inhibitors for treatment of eye disorders
US7070959B1 (en) 1999-06-08 2006-07-04 Regeneron Pharmaceuticals, Inc. Modified chimeric polypeptides with improved pharmacokinetic properties
EP1472275B1 (en) 2002-02-05 2008-12-17 Genentech, Inc. Protein purification
US7427659B2 (en) 2003-10-24 2008-09-23 Amgen Inc. Process for purifying proteins in a hydrophobic interaction chromatography flow-through fraction
BRPI0611600B8 (pt) * 2005-06-17 2021-05-25 Wyeth Corp método para purificação de uma proteína tendo uma região fc a partir de um líquido fonte compreendendo a proteína e uma ou mais impurezas, e kit
FR2894146B1 (fr) 2005-12-07 2008-06-06 Ifremer Utilisation d'un polysaccharide excrete par l'espece vibrio diabolicus a des fins d'ingenierie des tissus conjonctifs non mineralises
US8263750B2 (en) 2006-03-16 2012-09-11 Amgen Inc. Method for purifying a protein using protein-A affinity chromatography using an intermediate wash step
US7998927B2 (en) 2006-06-23 2011-08-16 Aegis Therapeutics, Llc Stabilizing alkylglycoside compositions and methods thereof
JP2010516651A (ja) 2007-01-17 2010-05-20 メルク セローノ ソシエテ アノニム Fc含有タンパク質の精製のための方法
CL2008002054A1 (es) 2007-07-17 2009-05-29 Hoffmann La Roche Metodo para la regeneracion de una columna de cromatografia de intercambio cationico despues de la elusion de eritropoyetina monopeguilada y metodo para obtener una eritropoyetina monopeguilada, incorporando el metodo de regeneracion de la columna de intercambio cationico.
JP5529869B2 (ja) 2008-08-14 2014-06-25 メルク・シャープ・アンド・ドーム・コーポレーション プロテインaアフィニティークロマトグラフィーを用いる抗体の精製方法
CA2932207A1 (en) 2008-10-20 2010-12-09 Abbvie Inc. Isolation and purification of antibodies using protein a affinity chromatography
CN105646643A (zh) 2008-10-29 2016-06-08 阿布林克斯公司 单域抗原结合性分子的纯化方法
WO2011038894A1 (en) 2009-10-01 2011-04-07 F. Hoffmann-La Roche Ag Protein a chromatography
NZ599100A (en) * 2009-10-20 2014-07-25 Abbvie Inc Isolation and purification of anti-il-13 antibodies using protein a affinity chromatography
BR112012014937B1 (pt) 2009-12-18 2021-01-19 Novartis Ag método de produção de um anticorpo, fragmento de anticorpo ou proteína de fusão fc purificada usando uma matriz de cromatografia de afinidade
WO2012078376A1 (en) 2010-12-08 2012-06-14 Amgen Inc. Ion exchange chromatography in the presence of an amino acid
TW201823460A (zh) 2012-05-29 2018-07-01 美商再生元醫藥公司 生產細胞株增強子
WO2015189832A1 (en) * 2014-06-13 2015-12-17 Lupin Limited Process for the purification of tnfr:fc fusion protein
EP3236772A4 (en) * 2014-12-22 2018-10-17 Alexion Pharmaceuticals, Inc. Methods of purifying recombinant proteins
TW201702380A (zh) * 2015-02-27 2017-01-16 再生元醫藥公司 宿主細胞蛋白質修飾
EP3294775B1 (en) 2015-05-12 2021-07-14 Regeneron Pharmaceuticals, Inc. Multimeric protein purity determination
CN106749660B (zh) * 2016-12-27 2020-02-14 嘉和生物药业有限公司 单克隆抗体下游纯化过程中有效去除宿主蛋白的方法
MY199833A (en) 2017-08-17 2023-11-24 Just Evotec Biologics Inc Method of purifying glycosylated protein from host cell galectins and other contaminants
JP2022520793A (ja) * 2019-02-15 2022-04-01 ジャスト-エヴォテック バイオロジックス、インコーポレイテッド 自動バイオ製造システム、施設、及びプロセス

Similar Documents

Publication Publication Date Title
ES2322945T5 (es) Métodos para purficación de proteína
JP4826995B2 (ja) 抗体の変質を防止する精製方法
Sachs et al. Antibodies to a distinct antigenic determinant of staphylococcal nuclease
EP1896506B1 (en) Methods of purifying anti a beta antibodies
Isackson et al. High mobility group chromosomal proteins isolated from nuclei and cytosol of cultured hepatoma cells are similar
JP5448825B2 (ja) 非凝集抗体Fcドメインの製造方法
JP5596078B2 (ja) 高アニオン性タンパク質の精製方法
WO2002066514A3 (en) Artificial fusion proteins with reduced immunogenicity
JP2012507557A5 (cg-RX-API-DMAC7.html)
Nilsson et al. Multiple affinity domains for the detection, purification and immobilization of recombinant proteins
WO2017168296A1 (en) A process for purification of fc-fusion proteins
EP3255058A1 (en) Protein having affinity to immunoglobulin, and affinity separation medium and column for liquid chromatography using same
Xia et al. Molecular modification of protein A to improve the elution pH and alkali resistance in affinity chromatography
EP3054009A1 (en) PROTEIN COMPRISED BY LINKING BY LINKER MULTIPLE DOMAINS HAVING AFFINITY FOR PROTEINS HAVING Fc PART OF IMMUNOGLOBULIN G (IgG)
US6613884B1 (en) Method for the removal/purification of serum albumins and means for use in the method
US20170226153A1 (en) Method for Separation of Biopolymer Molecules and a Carrier for Application of this Method
JPH02501985A (ja) 免疫複合体の選択的除去
JP2004537042A (ja) 非常に陰イオン性であるタンパク質を精製する方法
JP5635682B2 (ja) 疎水性相互作用クロマトグラフィー法
CN104379598B (zh) 高度糖基化的长效人生长激素蛋白及其生产方法
WO2023012828A1 (en) Method to purify an antibody composition using cation exchange chromatography
JP3346563B2 (ja) 組換え蛋白類を精製する改良方法および該方法で有用な化合物類
RU2081122C1 (ru) Способ выделения и очистки инсулина или его биотехнологических предшественников
JPWO2020066270A1 (ja) κ鎖可変領域を含む抗体および/または抗体断片の製造方法
CN113480613B (zh) 一种自剪切蛋白标签、改造方法及其应用